Current treatment paradigms and emerging therapies for NAFLD/NASH
Non-alcoholic fatty liver disease (NAFLD) is one the fastest emerging manifestations of the metabolic syndrome worldwide. Non-alcoholic steatohepatitis (NASH), the progressive form of NAFLD, may culminate into cirrhosis and hepatocellular cancer (HCC) and is presently a leading cause of liver transp...
Sparad:
| Huvudupphovsmän: | , , , , |
|---|---|
| Materialtyp: | Revisão |
| Språk: | engelska |
| Publicerad: |
2020
|
| Länkar: | https://doi.org/10.2741/4892 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|